Home Stock

Stock Research: Kalbe Farma

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Kalbe Farma

JKT:KLBF ID1000125107
89
  • Value
    94
  • Growth
    32
  • Safety
    Safety
    100
  • Combined
    97
  • Sentiment
    50
  • 360° View
    360° View
    89
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

PT Kalbe Farma Tbk is an Indonesian company engaged in developing, manufacturing, and trading pharmaceutical products. It operates in the pharmaceutical, consumer health, nutritional, and distribution industries. The company primarily operates in Indonesia. In the last fiscal year, the company had a market cap of $4,349 million, profits of $778 million, and revenue of $2,028 million, with 12,903 employees.

more

ANALYSIS: With an Obermatt 360° View of 89 (better than 89% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Kalbe Farma are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Kalbe Farma. The consolidated Value Rank has an attractive rank of 94, which means that the share price of Kalbe Farma is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 94% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 100. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 50. But the consolidated Growth Rank has a low rank of 32, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 68 of its competitors have better growth. ...read more

more
Strongest Rank Stock Returns
Weakest Rank Safety
Country Indonesia
Industry Pharmaceuticals
Size Large
Website kalbe.co.id
Index
IDX Composite
Kalbe Farma stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 9-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
94 77 69 69
Growth
32 17 17 45
Safety
Safety
100 79 79 81
Sentiment
50 99 63 79
360° View
360° View
89 89 65 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
89 76 38 69
Opinions Change
50 56 50 50
Pro Holdings
n/a 100 35 16
Market Pulse
49 100 95 95
Sentiment
50 99 63 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
94 77 69 69
Growth
32 17 17 45
Safety Safety
100 79 79 81
Combined
97 75 61 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
90 73 69 65
Price vs. Earnings (P/E)
82 70 58 48
Price vs. Book (P/B)
80 66 59 55
Dividend Yield
81 77 74 68
Value
94 77 69 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
44 25 23 27
Profit Growth
56 57 26 45
Capital Growth
40 20 92 85
Stock Returns
21 29 9 37
Growth
32 17 17 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
91 74 62 70
Refinancing
74 80 74 78
Liquidity
88 50 72 61
Safety Safety
100 79 79 81

Similar Stocks

Discover high‑ranked alternatives to Kalbe Farma and broaden your portfolio horizons.

MTN

JNB:MTN
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Indah Kiat

JKT:INKP
Country: Indonesia
Industry: Paper Products
Size: X-Large
Full Stock Analysis

PT Adaro Andalan Indonesia

JKT:AADI
Country: Indonesia
Industry: Coal & Consumable Fuels
Size: Large
Full Stock Analysis

Motiva Infraestrutura de Mobilidade

SAO:MOTV3
Country: Brazil
Industry: Highways & Railtracks
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews